Verastem (VSTM) Net Equity Issued and Repurchased (2011 - 2025)
Verastem (VSTM) posted quarterly Net Equity Issued and Repurchased of $96.9 million for Q4 2025, up 38.53% quarter-over-quarter from $69.9 million in Q2 2025.
Analysis
Verastem (VSTM) Net Equity Issued and Repurchased (2011 - 2025) Analysis & Trends
Verastem's Net Equity Issued and Repurchased history runs 10 years deep, the most recent figure standing at $96.9 million for Q4 2025.
- In Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $96.9 million; the TTM figure through Dec 2025 stood at $197.0 million (up 40630.04% YoY), while the FY2025 annual figure was $197.0 million, up 1285.11% from the prior year.
- Net Equity Issued and Repurchased for Q4 2025 stood at $96.9 million, up from $69.9 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $96.9 million in Q4 2025, with the low at -$486000.0 in Q3 2023.
- The 4-year median for Net Equity Issued and Repurchased is $3.9 million (2021), against an average of $23.1 million.
- The sharpest annual moves came in 2022 and 2023: Net Equity Issued and Repurchased soared 25434.0% in 2022, then slumped 101.9% in 2023.
- Verastem's Net Equity Issued and Repurchased stood at $6.5 million in 2021, then surged by 291.45% to $25.5 million in 2022, then sank by 101.9% to -$486000.0 in 2023, then soared by 20034.36% to $96.9 million in 2025.
- Business Quant data shows VSTM's Net Equity Issued and Repurchased at $96.9 million in Q4 2025, $69.9 million in Q2 2025, and $30.2 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Verastem | 815.85 Mn | 679.49 Mn | 36.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 96.88 Mn |
| Jun 30, 2025 | 69.93 Mn |
| Mar 31, 2025 | 30.16 Mn |
| Sep 30, 2023 | -486,000.00 |
| Sep 30, 2022 | 25.53 Mn |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 580,000.00 |
| Dec 31, 2021 | 6.52 Mn |
| Sep 30, 2021 | 100,000.00 |
| Mar 31, 2021 | 100,000.00 |
| Sep 30, 2020 | -10,000.00 |
| Jun 30, 2020 | 12.13 Mn |
| Mar 31, 2020 | 93.94 Mn |
| Sep 30, 2019 | 400,000.00 |
| Sep 30, 2018 | -301,000.00 |
| Jun 30, 2018 | 105.16 Mn |
| Mar 31, 2018 | 299,000.00 |
| Dec 31, 2015 | 51,000.00 |
| Sep 30, 2015 | 250,000.00 |
| Jun 30, 2015 | 6.20 Mn |